Document Details
Form
Filing Date
Feb 13, 2024
Document Date
Feb 13, 2024
Form Description
SEC Staff Letter: 14A-8
Company
Kyverna Therapeutics
Issuer
KYVERNA THERAPEUTICS, INC.